Sildenafil citrate nanoemulsion vs. self-nanoemulsifying delivery systems: Rational development and transdermal permeation

International Journal of Nanotechnology

Volumn 8, Issue 8-9, 2011, Pages 749-763

  Elnaggar, Yosra S R ^a   El Massik, Magda A ^b   Abdallah, Ossama Y ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

^b Pharos University of Alexandria   (Egypt)

Author keywords

Nanoemulsion; Nanotechnology; Sildenafil citrate; SNEDDS; Transdermal

Indexed keywords

DRUG PRODUCTS; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; MEDICAL NANOTECHNOLOGY; NANOTECHNOLOGY; SOLUBILITY; SURFACE ACTIVE AGENTS; TARGETED DRUG DELIVERY;

CLOUD POINT MEASUREMENTS; DRUG DELIVERY FORMULATIONS; NANOEMULSION; SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS); SILDENAFIL CITRATE; SNEDDS; TRANSDERMAL; TRANSDERMAL PERMEATION;

CONTROLLED DRUG DELIVERY;

EID: 79960803950     PISSN: 14757435     EISSN: None     Source Type: Journal    
DOI: 10.1504/IJNT.2011.041443     Document Type: Article

References (32)

1. Badwan, A.A., Nabulsi, L. and Al-Omari, M.M. (2001) 'Sildenafil citrate', Analytical Profiles of Drug Substances and Excipients, Publish Academic Press, New York, pp.372-376.
2. Eardley, I. (2010) 'Oral therapy for erectile dysfunction', Arch. Esp. Urol., Vol. 63, pp.703-714.
3. Nichols, D.J., Muirhead, G.J. and Harness, J.A. (2002) 'Pharmacokinetics of sildenafil citrate after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality', Br. J. Clin. Pharmacol., Vol. 53, pp.5-12.
4. Cevc, G. and Vierl, U. (2010) 'Nanotechnology and the transdermal route A state of the art review and critical appraisal', J. Controlled Release, Vol. 141, pp.277-299.
5. Bali, V., Ali, M. and Ali, J. (2010) 'Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe', Colloids Surf., B, Vol. 76, pp.410-420.
6. Vyas, T.K., Shahiwala. A. and Amiji, M.M. (2008) 'Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations', Int. J. Pharm., Vol. 347, pp.93-101. (Pubitemid 350180312)
7. Singh, K.K. and Vingkar, S.K. (2008) 'Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine', Int. J. Pharm., Vol. 347, pp.136-143. (Pubitemid 350180322)
8. Shafiq, S., Shakeel, F., Talegaonkar, S., Ahmad, F.J., Khar, R.K. and Ali, M. (2007) 'Development and bioavailability assessment of ramipril nanoemulsion formulation', Eur. J. Pharm. Biopharm., Vol. 66, pp.227-243. (Pubitemid 46667230)
9. Gao, F., Zhang, Z., Bu, H., Huang, Y., Gao, Z., Shen, J., Zhao, C. and Li, Y. (2011) 'Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: performance and mechanism', J. Controlled Release, Vol. 149, pp.168-174.
10. Shakeel, F., Baboota, S., Ahuja, A., Ali, J. and Shafiq, S. (2008) 'Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion', J. Nanobiotechnol., Vol. 9, pp.6-8.
11. Shakeel, F. and Ramadan, W. (2010) 'Transdermal delivery of anticancer drug caffeine from water-in-oil nanoemulsions', Colloids Surf., B, Vol. 75, pp.356-362.
12. Zheng, W.W., Zhao, L., Wei, Y.M., Ye, Y. and Xiao, S.H. (2010) 'Preparation and the in vitro evaluation of nanoemulsion system for the transdermal delivery of granisetron hydrochloride', Chem. Pharm. Bull. (Tokyo), Vol. 58, pp.1015-1019.
13. Klang, V., Matsko, N., Zimmermann, A., Vojnikovic, E. and Valenta, C. (2010) 'Enhancement of stability and skin permeation by sucrose stearate and cyclodextrins in progesterone nanoemulsions', Int. J. Pharm., Vol. 393, Nos. 1-2, pp.153-161.
14. Baspinar, Y., Keck, C.M. and Borchert, H.H. (2010) 'Development of a positively charged prednicarbate nanoemulsion' , Int. J. Pharm., Vol. 383, pp.201-208.
15. Elnaggar, Y.S.R., El-massik, M.A. and Abdallah, O.Y. (2009) 'Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization', Int. J. Pharm., Vol. 380, pp.133-141.
16. Wasan, E.K., Bartlett, K., Gershkovich, B., Sivak, O., Bannoe, B., Wong, Z., Gagnonc, J., Gatesf, B., Leonb, C.G. and Wasan, K.M. (2009) 'Development and characterization of oral lipid-based Amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans', Int. J. Pharm., Vol. 372, pp.76-84.
17. ® H35 based self-nanoemulsifying drug delivery system (SNEDDS) of coenzyme Q10', Eur. J. Pharm. Sci., Vol. 39, pp.224-232.
18. Holm, R., Porter, C.J.H., Edwards, G.A., Mullertz, A., Kristensen, H.G. and Charman, W.N. (2003) 'Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides', Eur. J. Pharm. Sci., Vol. 20, pp.91-97. (Pubitemid 37103236)
19. Zhang, P., Liu, Y., Feng, N. and Xu, J. (2008) 'Preparation and evaluation of self-microemulsifying drug delivery system of oridonin', Int. J. Pharm., Vol. 355, pp.269-276.
20. Rao, S.V.R. and Shao, J. (2008) 'Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: formulation development', Int. J. Pharm., Vol. 362, pp.2-9.
21. Ruan, J., Liu, J., Zhu, D., Gong, T., Yang, F., Hao, X. and Zhang, Z. (2010) 'Preparation and evaluation of self-nanoemulsified drug delivery systems (SNEDDSs) of matrine based on drug-phospholipid complex technique', Int. J. Pharm., Vol. 386, pp.282-290.
22. Zhaoa, Y., Wanga, C., Chowb, A.H.L., Renc, K., Gongc, T., Zhangc, Z. and Zheng, Y. (2010) 'Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: Formulation and bioavailability studies', Int. J. Pharm., Vol. 383, pp.170-177.
23. Basalious, E.B., Shawky, N. and Badr-Eldin, S.M. (2010) 'SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: Development and optimization', Int. J. Pharm., Vol. 391, pp.203-211.
24. Rane, S.S. and Anderson, B.D. (2008) 'What determines drug solubility in lipid vehicles: Is it predictable', Adv. Drug Delivery Rev., Vol. 60, pp.638-656.
25. Liaw, J. and Chang, T. (2001) 'Determination of transdermal sildenafil in nude mouse skin by reversed-phase high-performance liquid chromatography', J. Chromatogr. B, Vol. 765, pp.161-166. (Pubitemid 33079057)
26. Barbero, P.A.M. and Frasch, H.F. (2009) 'Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review', Toxicol. In Vitro, Vol. 23, pp.1-13.
27. Dragicevic-Curica, N., Grafeb, S., Gitter, S., Winterc, S. and Fahra, A. (2010) 'Surface charged temoporfin-loaded flexible vesicles: in vitro skin penetration studies and stability', Int. J. Pharm., Vol. 384, pp.100-108.
28. Shim, H.J., Lee, E.J., Jung, Y.H., Kim, S.H., Yoo, M., Kwon, J.W., Kim, W.B. and Lee, M.G. (2002) 'Determination of a new phosphodiesterase V inhibitor, DA-8159, in plasma and urine by high-performance liquid chromatography', J. Pharm. Biomed. Anal., Vol. 30, pp.527-533. (Pubitemid 35279681)
29. Porter, C.J.H., Pouton, C.W., Cuine, J.F. and Charman, W.N. (2008) 'Enhancing intestinal drug solubilization using lipid-based delivery systems ', Adv. Drug Delivery Rev., Vol. 60, pp.673-691.
30. Thanos, C.G., Liu, Z., Reineke, J., Edwards, E. and Mathiowitz, E. (2003) 'Improving relative bioavailability of dicumarol by reducing particle size and adding the adhesive poly (fumaric-co-sebacic) anhydride', Pharm. Res., Vol. 20, pp.1093-1100. (Pubitemid 36774281)
31. Kotyla, T., Kuob, F., Moolchandani, V., Wilson, T. and Nicolosi, R. (2008) 'Increased bioavailability of a transdermal application of a nano-sized emulsion preparation', Int. J. Pharm., Vol. 347, pp.144-148. (Pubitemid 350180323)
32. Chen, M.L. (2008) 'Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective', Adv. Drug Delivery Rev., Vol. 60, pp.768-777.